- Home
- CVEO vs ARCT Comparison
CVEO vs ARCT Comparison
Compare CVEO & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVEO
- ARCT
- Stock Information
- Founded
- CVEO 1977
- ARCT 2013
- Country
- CVEO United States
- ARCT United States
- Employees
- CVEO N/A
- ARCT N/A
- Industry
- CVEO Hotels/Resorts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CVEO Consumer Discretionary
- ARCT Health Care
- Exchange
- CVEO Nasdaq
- ARCT Nasdaq
- Market Cap
- CVEO 281.2M
- ARCT 298.3M
- IPO Year
- CVEO N/A
- ARCT N/A
- Fundamental
- Price
- CVEO $22.03
- ARCT $13.00
- Analyst Decision
- CVEO Strong Buy
- ARCT Strong Buy
- Analyst Count
- CVEO 1
- ARCT 8
- Target Price
- CVEO $27.00
- ARCT $52.33
- AVG Volume (30 Days)
- CVEO 90.1K
- ARCT 466.2K
- Earning Date
- CVEO 07-29-2025
- ARCT 05-12-2025
- Dividend Yield
- CVEO 4.51%
- ARCT N/A
- EPS Growth
- CVEO N/A
- ARCT N/A
- EPS
- CVEO N/A
- ARCT N/A
- Revenue
- CVEO $660,046,000.00
- ARCT $143,680,000.00
- Revenue This Year
- CVEO N/A
- ARCT N/A
- Revenue Next Year
- CVEO $4.45
- ARCT $42.36
- P/E Ratio
- CVEO N/A
- ARCT N/A
- Revenue Growth
- CVEO N/A
- ARCT 15.38
- 52 Week Low
- CVEO $18.01
- ARCT $8.04
- 52 Week High
- CVEO $28.92
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CVEO 63.83
- ARCT 57.72
- Support Level
- CVEO $21.51
- ARCT $11.51
- Resistance Level
- CVEO $21.99
- ARCT $13.60
- Average True Range (ATR)
- CVEO 0.46
- ARCT 0.88
- MACD
- CVEO 0.14
- ARCT 0.11
- Stochastic Oscillator
- CVEO 88.89
- ARCT 80.07
About CVEO Civeo Corporation (Canada)
Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.